GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

GLP-1 Receptor Agonist Use and Obesity-Related Cancer Risk Across Levels of Diabetes Severity

  • By

  • Jesús Gibran Hernández-Pérez

  • Omer Abdelgadir

  • Luisa Torres-Sánchez

  • Jing Chen

  • Jaime P. Almandoz

  • Lindsay G. Cowell

  • Sarah E. Messiah

  • David S. Lopez

  • November 3, 2026

Share

Original Source(s)

GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity

  • by Jesús Gibran Hernández-Pérez, Omer Abdelgadir, Luisa Torres-Sánchez, Jing Chen, Jaime P. Almandoz, Lindsay G. Cowell, Sarah E. Messiah, David S. Lopez

  • November 3, 2026

Related Content

A precision T-cell therapy stalls treatment-resistant cancers in clinical trial

  • October 23, 2026

Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology

Safety-Oriented Benchmarking of Large Language Models in Risk-Based Management of Abnormal Cervical Screening Results: Scenario-Based Benchmark Study